Controlled Substances (Controlled Drugs, Precursors and Plants) (Miscellaneous) Variation Regulations 2021 (SA)

South Australia

Controlled Substances (Controlled Drugs, Precursors and Plants) (Miscellaneous) Variation Regulations 2021

under the Controlled Substances Act 1984

Contents

Part 1—Preliminary

1            Short title

2            Commencement

3            Variation provisions

Part 2—Variation of Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014

4            Variation of Schedule 1—Controlled drugs

Part 1—Preliminary

1—Short title

These regulations may be cited as the Controlled Substances (Controlled Drugs, Precursors and Plants) (Miscellaneous) Variation Regulations 2021.

2—Commencement

These regulations come into operation on the day on which they are made.

3—Variation provisions

In these regulations, a provision under a heading referring to the variation of specified regulations varies the regulations so specified.

Part 2—Variation of Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014

4—Variation of Schedule 1—Controlled drugs

1. Schedule 1, Part 1—after the table entry relating to "Allylprodine" insert the following entry (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Alphamethadol 1 kg or 500 DDUs 0.2 kg or 100 DDUs 20 g or 50 DDUs

1. Schedule 1, Part 1—after the table entry relating to "Beta-hydroxy-3-methylfentanyl" insert the following entry (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Betamethadol 1 kg or 500 DDUs 0.2 kg or 100 DDUs 20 g or 50 DDUs

1. Schedule 1, Part 1—after the table entry relating to "Beta-phenyl-gamma-aminobutyric acid (Phenibut)" insert the following entry (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Betaprodine (excluding its stereoisomers) 1 kg 0.25 kg 1.5 g

1. Schedule 1, Part 1—after the table entry relating to "Dihydrohydroxymorphine" insert the following entry (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one (SGT-151) (cumyl-pegaclone) 12.5 kg or 100 DDUs 2.5 kg or 20 DDUs 250 g or 10 DDUs

1. Schedule 1, Part 1, table entry relating to "N-Ethyl-1-phenylcyclohexylamine"—delete the entry

2. Schedule 1, Part 1, table entry relating to "Methadol"—delete the entry

3. Schedule 1, Part 1, table entry relating to "Noracylmethadol"—delete the entry

4. Schedule 1, Part 1, table entry relating to "Noracymethadol"—delete the entry and substitute the following (such that the amounts specified in the second, third and fourth columns below appear in the table under the headings "Large commercial (mixed)", "Commercial (mixed)" and "Trafficable (mixed)" respectively):

Noracymethadol 1 kg or 500 DDUs 0.2 kg or 100 DDUs 20 g or 50 DDUs

1. Schedule 1, Part 1, table entry relating to "1-(1-Phenylcyclohexyl)pyrrolidine"—delete the entry

2. Schedule 1, Part 1, table entry relating to "Prodine"—delete the entry

3. Schedule 1, Part 1, table entry relating to "Tenocyclodine (TCP)"—delete "Tenocyclodine" and substitute:

   Tenocyclidine

4. Schedule 1, Part 1, table entry relating to "1-(1-(2-Thienyl)cyclohexyl)piperidine"—delete the entry

Note—

As required by section 10AA(2) of the Subordinate Legislation Act 1978, the Minister has certified that, in the Minister's opinion, it is necessary or appropriate that these regulations come into operation as set out in these regulations.

Made by the Administrator

on the recommendation of the Controlled Substances Advisory Council and with the advice and consent of the Executive Council

on 16 September 2021

No 143 of 2021